Back |
home / stock / kalv / kalv message board
Subject | By | Source | When |
---|---|---|---|
New buyer? They're not being bought, they're merging | Toxic Avenger | investorshub | 11/18/2016 7:59:44 PM |
Somethings fishy going on here. Why the sudden | beginneer | investorshub | 11/18/2016 7:46:37 PM |
Fun while it lasted. ;-) | Toxic Avenger | investorshub | 11/16/2016 7:12:06 PM |
Big bounce today. Anyone know why? | Toxic Avenger | investorshub | 11/14/2016 6:04:22 PM |
$700k / month for a company that has | Toxic Avenger | investorshub | 11/09/2016 1:47:26 AM |
Looks like an attempt to prevent the merger | Toxic Avenger | investorshub | 11/05/2016 10:18:24 AM |
Looks like an attempt to prevent the merger | Toxic Avenger | investorshub | 11/05/2016 10:18:23 AM |
Sadly, I don't think so. | Toxic Avenger | investorshub | 11/03/2016 11:51:28 PM |
Any idea what the general consensus among shareholders | MSparks6 | investorshub | 11/03/2016 11:49:15 PM |
LOL, $CBYL declined back to $0.49 again! The | Value_Investor | investorshub | 10/25/2016 4:12:06 PM |
Can you please stick that post#376 to the | Value_Investor | investorshub | 10/24/2016 3:28:12 PM |
Get him on the phone $NOW! | Toxic Avenger | investorshub | 10/22/2016 11:37:50 PM |
A New Merger proposal to the CEO of | Value_Investor | investorshub | 10/22/2016 10:44:58 PM |
$CBYL declined to $0.4984 so far from yesterday's | Value_Investor | investorshub | 10/21/2016 2:32:33 PM |
News, Short Squeeze, Breakout and More Instantly...
KalVista Pharmaceuticals Inc. Company Name:
KALV Stock Symbol:
NASDAQ Market:
KalVista Pharmaceuticals Inc. Website:
- Regulatory filings planned for US, EU, UK and Japan to enable multiple 2025 commercial launches – - Development strategy refined for oral Factor XIIa program – - Organizational focus to drive results and set path to positive cash flow – KalVist...
KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), a clinical stage pharmaceutical company focused on the discovery, development, and commercialization of oral, small molecule protease inhibitors, today announced that William C. Fairey has been appointed to the Company’s Board of Directors, ef...
2024-04-12 19:16:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...